CELL AND GENE THERAPY INSIGHTS

Filter by Interests

Filter by ContentType

Strategic partnering to enable cell therapy commercialization

Strategic partnering to enable cell therapy commercialization

02 October 2022
Expert Insight
 Challenges and proposed solutions to value assessment and reimbursement of CAR-T therapies in Europe

Challenges and proposed solutions to value assessment and reimbursement of CAR-T therapies in Europe

Clare Hague, Martin Price
28 August 2020
Expert Insight
 Immuno-oncology cell therapies: commercial considerations and strategies for the new decade

Immuno-oncology cell therapies: commercial considerations and strategies for the new decade

Glen Firestone
30 June 2020
Expert Insight
 Innovating CAR T cell therapy for today and tomorrow

Innovating CAR T cell therapy for today and tomorrow

David Chang
30 June 2020
Expert Insight
 Commercialization of TCR T-cell therapy: patient journey implications

Commercialization of TCR T-cell therapy: patient journey implications

Kimberly Freeman
17 June 2020
Expert Insight
 Innovation in Management as a Tool for Accelerated Translation of Advanced Therapies

Innovation in Management as a Tool for Accelerated Translation of Advanced Therapies

Nicholas Medcalf
05 April 2018
Expert Insight
 Automation in the context of stem cell production – where are we heading with Industry 4.0?

Automation in the context of stem cell production – where are we heading with Industry 4.0?

Jelena Ochs, Niels Konig
10 November 2016
Expert Insight
 Automating decentralized manufacturing of cell & gene therapy products

Automating decentralized manufacturing of cell & gene therapy products

Richard Harrison, Qasim Rafiq, Nicholas Medcalf
10 November 2016
Expert Insight
 Manufacturing process development of ATMPs within a regulatory framework for EU clinical trial & marketing authorisation applications

Manufacturing process development of ATMPs within a regulatory framework for EU clinical trial & marketing authorisation applications

10 November 2016
Expert Insight
 The evolving role of automation in process development & manufacture of cell & gene-based therapies

The evolving role of automation in process development & manufacture of cell & gene-based therapies

Qasim Rafiq, Robert Thomas
10 November 2016
Expert Insight
 Unlocking the therapeutic and commercial potential of CAR-T technology

Unlocking the therapeutic and commercial potential of CAR-T technology

Michelle Smith, Brittni Peterson, Barbara Nelsen
04 October 2016
Expert Insight
 The route to patient access: challenges of evaluating & funding new cell & gene therapies

The route to patient access: challenges of evaluating & funding new cell & gene therapies

Deborah Morrison, Nick Crabb
04 October 2016
Expert Insight
 Industry 4.0: a vision for personalized medicine supply chains?

Industry 4.0: a vision for personalized medicine supply chains?

Juergen Branke, Suzanne S Farid, Nilay Shah
06 July 2016
Expert Insight
 Drivers and methodologies for making cell therapy process changes

Drivers and methodologies for making cell therapy process changes

Gregory Russotti
21 March 2016
Expert Insight
 Centralized or decentralized manufacturing? Key business model considerations for cell therapies

Centralized or decentralized manufacturing? Key business model considerations for cell therapies

Nicholas Medcalf
21 March 2016
Expert Insight
 Revolutionizing genome editing with CRISPR/Cas9: patent battles and human embryos

Revolutionizing genome editing with CRISPR/Cas9: patent battles and human embryos

Hannah Smith-Willis, Beatriz San Martin
09 December 2015
Expert Insight